This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
RNS Hotlist with Zak Mir: AXL, LEX, GLR, 1SN, UJO, ANGS, CHLL, MIRI, GROC, ANA, IOG, GCAT, CRTM, VAST & CGNR
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
RNS Hotlist with Zak Mir: ANA, TLOU, CNS, AGL, JAN, BHL, LND, EML & SYN
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
Zak Mir talks to Melissa Sturgess, CEO Ananda Developments
In the wake of the MRX Global acquisition, and what this means for the medical cannabis group
RNS Hotlist with Zak Mir: ANA, ENSI, SYM, FRAN, ECO, FCM, PTAL, BLOE, VRCI, TLOU, AFC, FRG & SYN
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
RNS Hotlist with Zak Mir: RBD, PALM, FMET, ARS, CMET, SGZ, VELA, RMM, PANR & ANA via Vox Markets
Reabold Resources (RBD), the oil & gas investing company said it has now received its share of the initial gross consideration of £10 million (c. £3.2 million net to Reabold)
RNS Hotlist with Zak Mir: POLB, DVRG, SLE, KZG, SQZ, UKOG, SML, LND, ATM, OCTP, OPTI, GLR, IUG, ANA, AQRU, AGL & GENF
Poolbeg Pharma (POLB), a clinical-stage infectious disease pharmaceutical company, said it has received ethics and competent authority approval to commence its Lipopolysaccharide human challenge clinical trial for POLB 001, which
RNS Hotlist with Zak Mir: DVRG, PIRI, QBT, ORCP, MKA, ECO, UKOG, SRB, PERE & ANA via Vox Markets
There was a strong fundamental boost for DeepVerge’s (DVRG) environmental division, Modern Water, as it announced production orders up 39% in Q1, worth c£5m (Q1:2021 £3.6m) for a range of
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 21st September 2021 via Vox Markets
Zak Mir takes a technical analysis perspective on some of the most followed small-cap stocks on the London market. Today’s selection includes Ananda, Asimilar, Egdon, Igas, Kavango, Open Orphan, Oriole,
Ananda Developments Plc (ANA.L) Grant of Home Office Licence
The Directors of Ananda announce the following progress regarding Ananda’s vision to become a significant participant in the emerging medicinal cannabis sector:
The Best Of The Aquis Exchange YTD: ANA, COIN, KR1, LIFE, QTZ & VLRM
Aquis: The Top 20 Risers YTD courtesy Sharescope